Protokinetix Inc
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufa… Read more
Protokinetix Inc (PKTX) - Total Liabilities
Latest total liabilities as of September 2025: $227.20K USD
Based on the latest financial reports, Protokinetix Inc (PKTX) has total liabilities worth $227.20K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Protokinetix Inc - Total Liabilities Trend (2000–2024)
This chart illustrates how Protokinetix Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Protokinetix Inc Competitors by Total Liabilities
The table below lists competitors of Protokinetix Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kobexindo Tractors Tbk
JK:KOBX
|
Indonesia | Rp2.98 Trillion |
|
Birddog Technology Ltd
AU:BDT
|
Australia | AU$2.15 Million |
|
Cape Range Ltd
AU:CAG
|
Australia | AU$524.76K |
|
Conifex Timber Inc
PINK:CFXTF
|
USA | $143.50 Million |
|
GETS Global Bhd
KLSE:5079
|
Malaysia | RM299.24 Million |
|
TAKE-TWO INTERACT
BE:TKE
|
Germany | €7.28 Billion |
|
AS Latvijas balzams
MU:UM9
|
Germany | €55.41 Million |
|
Zwahlen et Mayr SA
SW:ZWM
|
Switzerland | CHF20.55 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Protokinetix Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Protokinetix Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Protokinetix Inc (2000–2024)
The table below shows the annual total liabilities of Protokinetix Inc from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $124.05K | +177.53% |
| 2023-12-31 | $44.70K | +7.62% |
| 2022-12-31 | $41.53K | -55.47% |
| 2021-12-31 | $93.27K | +107.45% |
| 2020-12-31 | $44.96K | +76.18% |
| 2019-12-31 | $25.52K | -67.65% |
| 2018-12-31 | $78.89K | -45.43% |
| 2017-12-31 | $144.56K | +219.16% |
| 2016-12-31 | $45.30K | -0.20% |
| 2015-12-31 | $45.39K | -89.55% |
| 2014-12-31 | $434.14K | -32.46% |
| 2013-12-31 | $642.79K | +31.15% |
| 2011-12-31 | $490.13K | -8.83% |
| 2010-12-31 | $537.60K | +4.93% |
| 2009-12-31 | $512.32K | +29.75% |
| 2008-12-31 | $394.85K | -3.42% |
| 2007-12-31 | $408.82K | -1.42% |
| 2006-12-31 | $414.70K | -16.66% |
| 2005-12-31 | $497.60K | -33.90% |
| 2004-12-31 | $752.84K | +357.89% |
| 2003-12-31 | $164.41K | +1253.87% |
| 2002-12-31 | $12.14K | +5972.00% |
| 2000-12-31 | $200.00 | -- |